Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimalarial drug-induced maculopathy prevalence study at Phra Nakhon Si Ayutthaya Hospital
TCTR20260801003Completed
- Sponsor
- NA
- Start
- Oct 2025
- Countries
- 1
01
Overview
Open-label trial in rheumatism (2 arms), sponsored by NA. Primary endpoint: Prevalence and risk factors for antimalarial drugs induced maculopathy. Started Oct 2025; status: completed.
02
Conditions
rheumatism
Beyond the preview
Go deeper on TCTR20260801003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260801003.